These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2827156)

  • 1. Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.
    Socher SH; Riemen MW; Martinez D; Friedman A; Tai J; Quintero JC; Garsky V; Oliff A
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8829-33. PubMed ID: 2827156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of specific high affinity receptors for human tumor necrosis factor on mouse fibroblasts.
    Hass PE; Hotchkiss A; Mohler M; Aggarwal BB
    J Biol Chem; 1985 Oct; 260(22):12214-8. PubMed ID: 2995366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitopic regions for antibodies against tumor necrosis factor alpha. Analysis by synthetic peptide mapping.
    Yone K; Bajard S; Tsunekawa N; Suzuki J
    J Biol Chem; 1995 Aug; 270(33):19509-15. PubMed ID: 7543899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.
    Smith RA; Kirstein M; Fiers W; Baglioni C
    J Biol Chem; 1986 Nov; 261(32):14871-4. PubMed ID: 3021754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective antibodies induced by a novel epitope of human TNF-alpha could suppress the development of collagen-induced arthritis.
    Dong J; Gao Y; Liu Y; Shi J; Feng J; Li Z; Pan H; Xue Y; Liu C; Shen B; Shao N; Yang G
    PLoS One; 2010 Jan; 5(1):e8920. PubMed ID: 20111721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of binding epitope of a monoclonal antibody (Z12) against human TNF-alpha using computer modeling and deletion mutant technique.
    Zhang W; Feng J; Shen B
    Sci China C Life Sci; 2004 Jun; 47(3):279-86. PubMed ID: 15524285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Computer modeling and experimental research of interactions between two anti-hTNF alpha monoclonal antibody variable regions and hTNF alpha].
    Chen JJ; Sun M; Fang J; Liu H; Chen CQ; Wang DB
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):36-41. PubMed ID: 10883273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-equine tumor necrosis factor (TNF) activity of antisera raised against human TNF-alpha and peptide segments of human TNF-alpha.
    MacKay RJ; Socher SH
    Am J Vet Res; 1992 Jun; 53(6):921-4. PubMed ID: 1378249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to peptide determinants in transforming growth factor beta and their applications.
    Flanders KC; Roberts AB; Ling N; Fleurdelys BE; Sporn MB
    Biochemistry; 1988 Jan; 27(2):739-46. PubMed ID: 2450577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an enzyme immunoassay for the measurement of human tumour necrosis factor-alpha (hTNF-alpha) using bispecific antibodies to hTNF-alpha and horseradish peroxidase.
    Berkova N; Karawajew L; Korobko V; Behrsing O; Micheel B; Shamborant O; Stukatcheva E; Shingarova L
    Biotechnol Appl Biochem; 1996 Apr; 23(2):163-71. PubMed ID: 8639273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase-catalyzed covalent multimerization of Camelidae anti-human TNF single domain antibodies improves neutralizing activity.
    Plagmann I; Chalaris A; Kruglov AA; Nedospasov S; Rosenstiel P; Rose-John S; Scheller J
    J Biotechnol; 2009 Jun; 142(2):170-8. PubMed ID: 19439388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
    Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
    Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of human tumor necrosis factor-alpha (hTNFalpha) chemically conjugated to monoclonal antibody.
    Pietersz GA; Toohey B; McKenzie IF
    J Drug Target; 1998; 5(2):109-20. PubMed ID: 9588867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic regions of tumor necrosis factor alpha and their topographic relationships with structural/functional domains.
    Corti A; Fassina G; Marcucci F; Cassani G
    Mol Immunol; 1992 Apr; 29(4):471-9. PubMed ID: 1373465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro.
    Hwang CD; Gatanaga M; Innins EK; Yamamoto RS; Granger GA; Gatanaga T
    Proc Biol Sci; 1991 Aug; 245(1313):115-9. PubMed ID: 1682934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the metastasis-enhancing potential of human tumor necrosis factor alpha by introducing the cell-adhesive Arg-Gly-Asp sequence.
    Miyata K; Mitsuishi Y; Shikama H; Kuroda K; Nishimura K; Sakae N; Kato M
    J Interferon Cytokine Res; 1995 Feb; 15(2):161-9. PubMed ID: 8590320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of RGD tumor-homing peptide conjugated human tumor necrosis factor alpha over-expressed in Escherichia coli.
    Ma D; Chen Y; Fang L; Jin G; Zhou B; Cao L; Ye J; Hua Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):231-9. PubMed ID: 17716959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P
    Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.